The AbATE Trial for Type 1 Diabetes
Home FAQs Glossary of terms Contact Us
The AbATE Trial for Type 1 Diabetes What is teh AbATE Trial? Who can Participate? What is ALA3 Antibody? Find a clinical center About Clinical Trials

Patient & Physician Enquiries

Please contact the study coordinator at the nearest clinical site for more information, including information on eligibility and/or enrollment or call the AbATE Trial Hotline at:

1-877-STOP-T1D
(1-877-786-7813)

You may also contact the central study coordinator directly:

Kimberly Kunze, RN
Study Coordinator
Yale Diabetes Research Program
Phone: (203) 785-7407   
E-mail: info@abatetrial.org

 

Media Enquiries

Media enquiries should be directed to:

Jeffrey B. Matthews, PhD
Director of Communications
Immune Tolerance Network
Phone: (604) 921-6597
Email: jmatthews@immunetolerance.org

 

 

 



Click here to find out if this trial is right for you or a member of your family.


Click here to find out which of the clinical centers in the US and Canada is closest to you.


Enter your email address below to receive updates on the AbATE trial.

 

 

 

 

 

 

 

Copyright 2005-8 Immune Tolerance Network. All rights reserved.